We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Antibacterial Drug Study Guidance Recommends Nonclinical Studies
Antibacterial Drug Study Guidance Recommends Nonclinical Studies
September 18, 2009
Sponsors are advised to consider a range of factors in determining the types of infections their systemic antibacterial products will treat and submit results from nonclinical studies before beginning Phase II clinical trials.